Author
Listed:
- Niclas Roxhed
(KTH Royal Institute of Technology
Karolinska University Hospital)
- Annika Bendes
(KTH Royal Institute of Technology)
- Matilda Dale
(KTH Royal Institute of Technology)
- Cecilia Mattsson
(KTH Royal Institute of Technology)
- Leo Hanke
(Karolinska Institutet)
- Tea Dodig-Crnković
(KTH Royal Institute of Technology)
- Murray Christian
(Karolinska Institutet)
- Birthe Meineke
(Division of Genome Biology
Karolinska Institutet)
- Simon Elsässer
(Division of Genome Biology
Karolinska Institutet)
- Juni Andréll
(Stockholm University)
- Sebastian Havervall
(Danderyd Hospital)
- Charlotte Thålin
(Danderyd Hospital)
- Carina Eklund
(Karolinska University Hospital)
- Joakim Dillner
(Karolinska University Hospital)
- Olof Beck
(Karolinska Institutet)
- Cecilia E. Thomas
(KTH Royal Institute of Technology)
- Gerald McInerney
(Karolinska Institutet)
- Mun-Gwan Hong
(KTH Royal Institute of Technology)
- Ben Murrell
(Karolinska Institutet)
- Claudia Fredolini
(KTH Royal Institute of Technology)
- Jochen M. Schwenk
(KTH Royal Institute of Technology)
Abstract
Serological testing is essential to curb the consequences of the COVID-19 pandemic. However, most assays are still limited to single analytes and samples collected within healthcare. Thus, we establish a multianalyte and multiplexed approach to reliably profile IgG and IgM levels against several versions of SARS-CoV-2 proteins (S, RBD, N) in home-sampled dried blood spots (DBS). We analyse DBS collected during spring of 2020 from 878 random and undiagnosed individuals from the population in Stockholm, Sweden, and use classification approaches to estimate an accumulated seroprevalence of 12.5% (95% CI: 10.3%–14.7%). This includes 5.4% of the samples being IgG+IgM+ against several SARS-CoV-2 proteins, as well as 2.1% being IgG−IgM+ and 5.0% being IgG+IgM− for the virus’ S protein. Subjects classified as IgG+ for several SARS-CoV-2 proteins report influenza-like symptoms more frequently than those being IgG+ for only the S protein (OR = 6.1; p
Suggested Citation
Niclas Roxhed & Annika Bendes & Matilda Dale & Cecilia Mattsson & Leo Hanke & Tea Dodig-Crnković & Murray Christian & Birthe Meineke & Simon Elsässer & Juni Andréll & Sebastian Havervall & Charlotte , 2021.
"Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2,"
Nature Communications, Nature, vol. 12(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23893-4
DOI: 10.1038/s41467-021-23893-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23893-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.